Buy Stocks Easy | About Us
September 28, 2021
Buy Stocks Easy | Online Stocks

LXRX


Buy Lexicon Pharmaceuticals, Inc. Stock (symbol: LXRX) Easy Online

Company Name: Lexicon Pharmaceuticals, Inc.

Symbol: LXRX

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2000

LXRX Current Share Price

Today's LXRX ( Lexicon Pharmaceuticals, Inc. ) opening price: $

Yesterday's LXRX ( Lexicon Pharmaceuticals, Inc. ) closing price: $

Lexicon Pharmaceuticals, Inc. Stock ( symbol: LXRX ) Price Chart since IPO (2000):

12 Months Lexicon Pharmaceuticals, Inc. Stock ( symbol: LXRX ) Price Chart

Popular Questions about Lexicon Pharmaceuticals, Inc. Public Stock ( LXRX )

A: Lexicon Pharmaceuticals, Inc. stock symbol (also called stock or share ticker) is LXRX

A: Lexicon Pharmaceuticals, Inc. IPO (Initial Public Offering) took place on 2000

A: Lexicon Pharmaceuticals, Inc.'s stock (LXRX symbol) price at ther IPO (initial Public Offering) was $

Q: Is LXRX stock worth buying at the moment?

A: The LXRX stock performance since 2019 are rather disappointing. If you had bought 1 share of Lexicon Pharmaceuticals, Inc. stock (symbol: LXRX) at the beginning of 2019, at the opening share price of $4.7300, you would be left with exactly $ - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Lexicon Pharmaceuticals, Inc. Stock Easy Online

Lexicon Pharmaceuticals, Inc. Stock Ticker Price Chart since IPO:





Lexicon Pharmaceuticals, Inc. Stock Price Yesterday



 


Lexicon Pharmaceuticals, Inc. Stock Price – Last Week




 


Lexicon Pharmaceuticals, Inc. Stock Price – Last Month




 


Lexicon Pharmaceuticals, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.zacks.com/stock/news/668882/implied-volatility-surging-for-lexicon-lxrx-stock-options
                            

                                
Implied Volatility Surging for Lexicon (LXRX) Stock Options

                                
                                
Investors need to pay close attention to Lexicon (LXRX) stock based...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/05/1956686/0/en/Lexicon-Pharmaceuticals-Announces-Positive-Topline-Phase-1-Data-for-LX9211.html
                            

                                
Lexicon Pharmaceuticals Announces Positive Topline Phase 1 Data for LX9211

                                
                                
THE WOODLANDS, Texas, Dec.  05, 2019  (GLOBE NEWSWIRE) --  Lexicon ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/03/1955402/0/en/Lexicon-Pharmaceuticals-Completes-Safety-Review-of-Initial-Safety-Run-in-Cohort-of-TELE-ABC-Study-a-Phase-2-Clinical-Study-of-Telotristat-Ethyl-in-Biliary-Tract-Cancer.html
                            

                                
Lexicon Pharmaceuticals Completes Safety Review of Initial Safety Run-in Cohort of TELE-ABC Study, a Phase 2 Clinical Study of Telotristat Ethyl in Biliary Tract Cancer

                                
                                
THE WOODLANDS, Texas, Dec.  03, 2019  (GLOBE NEWSWIRE) --  Lexicon ...


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/general/biotech/19/12/14912688/why-lexicon-pharma-shares-are-moving-lower
                            

                                
Why Lexicon Pharma Shares Are Moving Lower

                                
                                
Lexicon Pharmaceuticals, Inc. shares were retreating sharply Monday...


                            

                        
                    

                


                            

                    


                        
                            https://www.marketwatch.com/story/lexicon-pharmaceuticals-stock-slides-15-premarket-after-fda-denies-appeal-of-decision-relating-to-diabetes-drug-2019-12-02
                            

                                
Lexicon Pharmaceuticals stock slides 15% premarket after FDA denies appeal of decision relating to diabetes drug

                                
                                
Lexicon Pharmaceuticals Inc. shares LXRX, -0.84% slid 15% in premar...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/11/27/is-lexicon-pharmaceuticals-a-buy.aspx
                            

                                
Is Lexicon Pharmaceuticals a Buy?

                                
                                
Despite doubts over its lead drug candidate and the loss of a major...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/15/1947706/0/en/Lexicon-Pharmaceuticals-to-Present-at-Upcoming-Investor-Conference.html
                            

                                
Lexicon Pharmaceuticals to Present at Upcoming Investor Conference

                                
                                
THE WOODLANDS, Texas, Nov.  14, 2019  (GLOBE NEWSWIRE) -- Lexicon P...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/619576/are-investors-undervaluing-lexicon-pharmaceuticals-lxrx-right-now
                            

                                
Are Investors Undervaluing Lexicon Pharmaceuticals (LXRX) Right Now?

                                
                                
Here at Zacks, our focus is on the proven Zacks Rank system, which ...


                            

                        
                    

                


                            

                    


                        
                            https://www.marketwatch.com/story/lexicon-shares-fall-on-diabetes-study-data-2019-12-20
                            

                                
Lexicon shares fall on diabetes study data

                                
                                
Shares of Lexicon Pharmaceuticals Inc. are down 5% in premarket tra...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/20/1963393/0/en/Lexicon-Pharmaceuticals-Announces-Topline-Phase-3-Data-for-Sotagliflozin-in-Type-2-Diabetes.html
                            

                                
Lexicon Pharmaceuticals Announces Topline Phase 3 Data for Sotagliflozin in Type 2 Diabetes

                                
                                
THE WOODLANDS, Texas, Dec.  20, 2019  (GLOBE NEWSWIRE) --  Lexicon ...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/668882/implied-volatility-surging-for-lexicon-lxrx-stock-options
                            

                                
Implied Volatility Surging for Lexicon (LXRX) Stock Options

                                
                                
Investors need to pay close attention to Lexicon (LXRX) stock based...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/05/1956686/0/en/Lexicon-Pharmaceuticals-Announces-Positive-Topline-Phase-1-Data-for-LX9211.html
                            

                                
Lexicon Pharmaceuticals Announces Positive Topline Phase 1 Data for LX9211

                                
                                
THE WOODLANDS, Texas, Dec.  05, 2019  (GLOBE NEWSWIRE) --  Lexicon ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/03/1955402/0/en/Lexicon-Pharmaceuticals-Completes-Safety-Review-of-Initial-Safety-Run-in-Cohort-of-TELE-ABC-Study-a-Phase-2-Clinical-Study-of-Telotristat-Ethyl-in-Biliary-Tract-Cancer.html
                            

                                
Lexicon Pharmaceuticals Completes Safety Review of Initial Safety Run-in Cohort of TELE-ABC Study, a Phase 2 Clinical Study of Telotristat Ethyl in Biliary Tract Cancer

                                
                                
THE WOODLANDS, Texas, Dec.  03, 2019  (GLOBE NEWSWIRE) --  Lexicon ...


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/general/biotech/19/12/14912688/why-lexicon-pharma-shares-are-moving-lower
                            

                                
Why Lexicon Pharma Shares Are Moving Lower

                                
                                
Lexicon Pharmaceuticals, Inc. shares were retreating sharply Monday...


                            

                        
                    

                


                            

                    


                        
                            https://www.marketwatch.com/story/lexicon-pharmaceuticals-stock-slides-15-premarket-after-fda-denies-appeal-of-decision-relating-to-diabetes-drug-2019-12-02
                            

                                
Lexicon Pharmaceuticals stock slides 15% premarket after FDA denies appeal of decision relating to diabetes drug

                                
                                
Lexicon Pharmaceuticals Inc. shares LXRX, -0.84% slid 15% in premar...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/11/27/is-lexicon-pharmaceuticals-a-buy.aspx
                            

                                
Is Lexicon Pharmaceuticals a Buy?

                                
                                
Despite doubts over its lead drug candidate and the loss of a major...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.